As the race to develop a Covid-19 vaccine heats up, a debate is arising over how to balance expediency with safety measures. Watch five experts weigh in on how companies developing a vaccine can handle the issue.
Five experts on balancing speed with safety in development of Covid-19 vaccine
More Stories
Brazil rolls out COVID-19 vaccination plan
First Pfizer COVID-19 vaccine shipments to be delivered to US distribution sites starting Monday
CDC advisory panel recommends Covid-19 vaccine for people 16 and over